Importantly, the synergy between anti-PD1 treatment and DR feeding was abolished when T cells were unable to process ketone bodies; under DR feeding, DKO mice treated with anti-PD1 antibodies showed no extension in tumour-free survival compared with IgG controls (Fig. 7g). Here, PDCD1 is linked to neoplasm.